These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31907148)

  • 21. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of electroacupuncture intervention on changes of quality of ovum and pregnancy out- come in patients with polycystic ovarian syndrome].
    Yang BZ; Cui W; Li J
    Zhen Ci Yan Jiu; 2015 Apr; 40(2):151-6. PubMed ID: 26054202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of electro-acupuncture on the spindle and oocytes quality in patients with PCOS].
    Li J; Cui W; Sun W; Zhang QY; Guan Q
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):304-9. PubMed ID: 25951635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
    Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
    J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.
    Kadoura S; Alhalabi M; Nattouf AH
    Ann Med Surg (Lond); 2022 Jul; 79():104096. PubMed ID: 35860057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.
    Grynnerup AG; Toftager M; Zedeler A; Bogstad JW; Prætorius L; Grøndahl ML; Yding Andersen C; Sørensen S; Pinborg A; Løssl K
    J Assist Reprod Genet; 2018 Dec; 35(12):2187-2193. PubMed ID: 30232642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome].
    Li X; Ding W; Liu JY; Mao YD; Huang J; Wang W; Ma X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):402-408. PubMed ID: 29961283
    [No Abstract]   [Full Text] [Related]  

  • 30. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
    Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
    Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of bushen tiaojing recipe on the quality of the oocytes and reproductive hormones in the follicular fluid in IVF-ET patients].
    Liang Y; Du HL; Chang XF; Zhao SN; Lei LM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):911-6. PubMed ID: 25223171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
    Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation].
    Kdous M; Chaker A; Bouyahia M; Zhioua F; Zhioua A
    Tunis Med; 2009 Dec; 87(12):834-42. PubMed ID: 20209851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidative stress and female infertility: the role of follicular fluid soluble receptor of advanced glycation end-products (sRAGE) in women with endometriosis.
    Sopasi F; Spyropoulou I; Kourti M; Vasileiadis S; Tripsianis G; Galazios G; Koutlaki N
    Hum Fertil (Camb); 2023 Dec; 26(6):1400-1407. PubMed ID: 37811816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol.
    Schoolcraft W; Schlenker T; Gee M; Stevens J; Wagley L
    Fertil Steril; 1997 Jan; 67(1):93-7. PubMed ID: 8986690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity.
    Aydogan Mathyk B; Aslan Cetin B; Vardagli D; Zengin E; Sofiyeva N; Irez T; Ocal P
    Taiwan J Obstet Gynecol; 2018 Apr; 57(2):194-199. PubMed ID: 29673660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve.
    Tong J; Sheng S; Sun Y; Li H; Li WP; Zhang C; Chen ZJ
    Reproduction; 2017 Apr; 153(4):443-451. PubMed ID: 28062641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of Shen invigorating and Chong-channel regulating method on anti-Müllerian hormone and oocyte quality in polycystic ovarian syndrome patients].
    Lian F; Zhao S
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):9-12. PubMed ID: 22500381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. sRAGE plays a role as a protective factor in the development of PCOS by inhibiting inflammation.
    Wang BJ; Qian L; Li J; Wang F; Yang QL; Li G; Liang YL; Guo YH
    Gynecol Endocrinol; 2020 Feb; 36(2):148-151. PubMed ID: 31248316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.